Molecular simulations explain the effects of the p.(L2026M+G2032R) double mutation in ROS1 on targeted TKI treatment

Christa Dijkhuizen (First author), Patrick Korthuis, Lyndsay Drayer, Margot De Looff, Fin Milder, Anke van den Berg, Anthonie van der Wekken, Tsjerk Wassenaar

Research output: Contribution to conferenceAbstractAcademic

Original languageEnglish
Number of pages1
Publication statusSubmitted - 26 Aug 2025
EventEMBL Heidelberg EMBO Computational Structural Biology - Heidelberg, Germany
Duration: 2 Dec 20255 Dec 2025

Conference

ConferenceEMBL Heidelberg EMBO Computational Structural Biology
Abbreviated titleEMBL 2025
Country/TerritoryGermany
CityHeidelberg
Period2/12/255/12/25

Keywords

  • ROS1
  • ROS1 inhibitors
  • molecular dynamics simulation
  • Principal Component Analysis

Research Focus Areas Hanze University of Applied Sciences * (mandatory by Hanze)

  • Healthy Ageing

Research Focus Areas Research Centre or Centre of Expertise * (mandatory by Hanze)

  • Medical Diagnostics & Point of Care Testing
  • Healthcare & Biotechnology

Publinova themes

  • Health

Cite this